FilingIndex
AGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-KAGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-K
← KYMR · Kymera Therapeutics, Inc.
DEFA14AThe Ballot

Kymera Therapeutics, Inc. files DEFA14A

Filed Apr 27, 2023 · 3y ago · Accession 0001193125-23-122156

Plain English

DEFA14A filed with the SEC.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Company
Kymera Therapeutics, Inc.
Ticker
KYMR
CIK
1815442
Form type
DEFA14A
Filing date
Apr 27, 2023
Report date
—
Document
d482318ddefa14a.htm
Size
698 KB

More from KYMR

SC 13D/AThe StakesJun 26, 20268-KReg FD Disclosure · Company UpdateJun 25, 20268-KShareholder VoteJun 24, 20268-KExecutive ChangeJun 8, 20268-KResults of OperationsApr 30, 202610-QThe RecordApr 30, 2026